Table 3.
Oocyte samples | Effective reads (%) | Total mapped (%) | Multiple mapped (%) | Uniquely mapped (%) |
---|---|---|---|---|
GV-1 | 33,932,434 (100%) | 30,555,997 (90.05%) | 984,131 (2.90%) | 29,571,866 (87.15%) |
GV-2 | 36,638,364 (100%) | 32,856,839 (89.68%) | 1,014,903 (2.77%) | 31,841,936 (86.91%) |
GV-3 | 32,629,768 (100%) | 29,522,251 (90.48%) | 888,004 (2.72%) | 28,634,247 (87.75%) |
GV-4 | 25,925,760 (100%) | 24,228,123 (93.45%) | 743,254 (2.87%) | 23,484,869 (90.59%) |
MI-1 | 35,920,126 (100%) | 32,427,318 (90.28%) | 1,024,168 (2.85%) | 31,403,150 (87.42%) |
MI-2 | 32,936,256 (100%) | 29,447,176 (89.41%) | 980,844 (2.98%) | 28,466,332 (86.43%) |
MI-3 | 32,497,504 (100%) | 29,655,197 (91.25%) | 990,528 (3.05%) | 28,664,669 (88.21%) |
MI-4 | 34,142,352 (100%) | 30,981,358 (90.74%) | 1,055,072 (3.09%) | 29,926,286 (87.65%) |
MII-1 | 34,275,096 (100%) | 30,556,956 (89.15%) | 1,122,785 (3.28%) | 29,434,171 (85.88%) |
MII-2 | 24,449,952 (100%) | 21,740,489 (88.92%) | 803,235 (3.29%) | 20,937,254 (85.63%) |
MII-3 | 38,783,590 (100%) | 34,023,241 (87.73%) | 1,287,335 (3.32%) | 32,735,906 (84.41%) |
MII-4 | 29,087,318 (100%) | 26,757,178 (91.99%) | 776,998 (2.67%) | 25,980,180 (89.32%) |
ROMA-1 | 38,427,514 (100%) | 35,695,813 (92.89%) | 1,180,687 (3.07%) | 34,515,126 (89.82%) |
ROMA-2 | 39,906,932 (100%) | 37,132,703 (93.05%) | 1,157,668 (2.90%) | 35,975,035 (90.15%) |
ROMA-3 | 29,965,726 (100%) | 27,654,693 (92.29%) | 954,987 (3.19%) | 26,699,706 (89.10%) |
ROMA-4 | 31,189,304 (100%) | 29,038,612 (93.10%) | 985,247 (3.16%) | 28,053,365 (89.95%) |